Clinical Scorecard: Diphtheria Resurgence in Guinea: Analyzing Vaccination Efforts and Disease Management Strategies During the Outbreak

At a Glance

Key Highlights

• In the 2023 Guinea outbreak, 20.3% of suspected cases were confirmed diphtheria with an 8.9% fatality rate.
• Key clinical signs significantly associated with diphtheria positivity include whitish throat membrane and dyspnea.
• Low vaccination coverage (24% fully vaccinated in children 12–23 months) contributed to disease resurgence.

Guideline-Based Recommendations

Diagnosis

• Suspect diphtheria if patient presents at least two symptoms: fever, sore throat, reddened throat, cervical lymph node swelling, difficulty breathing, throat irritation, cough, swallowing difficulties, or whitish/grayish throat membrane.
• Confirm diagnosis by detecting diphtheria toxin genes (toxA and toxB) via two RT-qPCR tests on nasopharyngeal/oropharyngeal swabs.
• Classify cases as suspected, epidemiologically linked, clinically compatible, or discarded based on clinical and laboratory criteria.

Management

• Early recognition of characteristic signs (whitish throat membrane, dyspnea) to initiate prompt treatment.
• Provide care in epidemic treatment centers with supportive management to reduce severity and mortality.
• Prioritize vaccination campaigns to increase coverage and prevent further outbreaks.

Monitoring & Follow-up

• Conduct epidemiological surveillance to track suspected and confirmed cases.
• Monitor vaccination coverage rates, especially in children under 2 years.
• Follow up on fatality rates and time to death post-admission to assess outbreak severity.

Risks

• Age under 15 years increases risk of diphtheria infection.
• Lack of prior vaccination significantly raises susceptibility.
• Contact with confirmed diphtheria cases is a major exposure risk.

Patient & Prescribing Data

Children under 15 years, particularly those unvaccinated or partially vaccinated in Guinea

Early diagnosis and treatment are critical; vaccination remains the most effective preventive measure to reduce incidence and mortality.

Clinical Best Practices

• Use RT-qPCR testing for definitive diagnosis of diphtheria toxin presence.
• Recognize and prioritize treatment for patients presenting with whitish throat membrane and dyspnea.
• Implement and strengthen vaccination programs targeting children under 2 years to improve coverage.
• Maintain cold chain and proper sample handling for accurate laboratory confirmation.
• Educate healthcare workers on clinical case definitions and epidemiological links to improve case detection.

References

• World Health Organization Diphtheria Factsheet
• Guinea National Agency for Food Safety Report 2024
• 2018 Demographic and Health Survey Guinea